MRGPRX2 and Immediate Drug Hypersensitivity: Insights From Cultured Human Mast Cells

Elst, J; Sabato, V; Faber, M. A; Bridts, C. H; Mertens, C; Van Houdt, M; Van Gasse, A. L; Hagendorens, M. M; Van Tendeloo, V; Maurer, M.
J. investig. allergol. clin. immunol ; 31(6): 489-499, 2021. graf
Artículo en Inglés | IBECS (España) | ID: ibc-216776

Documentos relacionados

  1. [Drug hypersensitivity in patients with presumed histamine intolerance and mast cell activation disease].
  2. Mastocytosis and the Fig Wasp (Blastophaga psenes).
  3. Mast Cells as Drivers of Disease and Therapeutic Targets.
  4. Licensed to Ill: IL-9 Generation in Immature Mast Cells Permits Food-Elicited Anaphylaxis.
  5. Mastering gut permeability: New roles for old friends.
  6. Omalizumab in the treatment of adult patients with mastocytosis: A systematic review.
  7. [Mastocytosis : Clinical aspects, diagnostics, therapy].
  8. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
  9. Primary mast cell disorders in children.
  10. Inherited and acquired determinants of serum tryptase levels in humans.